Articoli con mandati relativi all'accesso pubblico - Christine DesmedtUlteriori informazioni
Non disponibili pubblicamente: 7
Controlla
A single-cell map of intratumoral changes during anti-PD1 treatment of patients with breast cancer
A Bassez, H Vos, L Van Dyck, G Floris, I Arijs, C Desmedt, B Boeckx, ...
Nature medicine 27 (5), 820-832, 2021
Mandati: Research Foundation (Flanders), European Commission
Controlla
Infrared imaging in breast cancer: automated tissue component recognition and spectral characterization of breast cancer cells as well as the tumor microenvironment
A Benard, C Desmedt, M Smolina, P Szternfeld, M Verdonck, G Rouas, ...
Analyst 139 (5), 1044-1056, 2014
Mandati: National Fund for Scientific Research, Belgium
Controlla
Differential benefit of adjuvant docetaxel-based chemotherapy in patients with early breast cancer according to baseline body mass index
C Desmedt, M Fornili, F Clatot, R Demicheli, D De Bortoli, A Di Leo, ...
Journal of Clinical Oncology 38 (25), 2883-2891, 2020
Mandati: Fondazione AIRC per la Ricerca sul Cancro
Controlla
Loss of ARID1A activates ANXA1, which serves as a predictive biomarker for trastuzumab resistance
K Berns, A Sonnenblick, A Gennissen, S Brohée, EM Hijmans, B Evers, ...
Clinical Cancer Research 22 (21), 5238-5248, 2016
Mandati: Netherlands Organisation for Scientific Research, Dutch Cancer Society
Controlla
Transcriptomic and genomic features of invasive lobular breast cancer
C Desmedt, G Zoppoli, C Sotiriou, R Salgado
Seminars in cancer biology 44, 98-105, 2017
Mandati: Susan G. Komen
Controlla
Aspartate signalling drives lung metastasis via alternative translation
G Doglioni, J Fernández-García, S Igelmann, P Altea-Manzano, ...
Nature, 1-7, 2025
Mandati: European Commission
Controlla
Aging-accumulated methylmalonic acid serum levels at breast cancer diagnosis are not associated with distant metastases
Q Wu, S Hatse, C Kenis, J Fernández-García, P Altea-Manzano, J Billen, ...
Breast Cancer Research and Treatment 205 (3), 555-565, 2024
Mandati: European Commission, World Cancer Researh Fund, UK
Disponibili pubblicamente: 109
Controlla
Signatures of mutational processes in human cancer
LB Alexandrov, S Nik-Zainal, DC Wedge, SAJR Aparicio, S Behjati, ...
nature 500 (7463), 415-421, 2013
Mandati: US National Institutes of Health, Wellcome Trust
Controlla
Landscape of somatic mutations in 560 breast cancer whole-genome sequences
S Nik-Zainal, H Davies, J Staaf, M Ramakrishna, D Glodzik, X Zou, ...
Nature 534 (7605), 47-54, 2016
Mandati: US Department of Energy, US National Institutes of Health, National Fund for …
Controlla
The landscape of cancer genes and mutational processes in breast cancer
PJ Stephens, PS Tarpey, H Davies, P Van Loo, C Greenman, DC Wedge, ...
Nature 486 (7403), 400-404, 2012
Mandati: US National Institutes of Health, Research Foundation (Flanders), National …
Controlla
Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial
S Loi, S Michiels, R Salgado, N Sirtaine, V Jose, D Fumagalli, ...
Annals of oncology 25 (8), 1544-1550, 2014
Mandati: National Health and Medical Research Council, Australia, Susan G. Komen
Controlla
Biological processes associated with breast cancer clinical outcome depend on the molecular subtypes
C Desmedt, B Haibe-Kains, P Wirapati, M Buyse, D Larsimont, ...
Clinical cancer research 14 (16), 5158-5165, 2008
Mandati: Swiss National Science Foundation
Controlla
Subclonal diversification of primary breast cancer revealed by multiregion sequencing
LR Yates, M Gerstung, S Knappskog, C Desmedt, G Gundem, P Van Loo, ...
Nature medicine 21 (7), 751-759, 2015
Mandati: US Department of Energy, Research Foundation (Flanders), Wellcome Trust
Controlla
Genomic evolution of breast cancer metastasis and relapse
LR Yates, S Knappskog, D Wedge, JHR Farmery, S Gonzalez, ...
Cancer cell 32 (2), 169-184. e7, 2017
Mandati: US Department of Energy, Netherlands Organisation for Scientific Research …
Controlla
Extensive transduction of nonrepetitive DNA mediated by L1 retrotransposition in cancer genomes
JMC Tubio, Y Li, YS Ju, I Martincorena, SL Cooke, M Tojo, G Gundem, ...
Science 345 (6196), 1251343, 2014
Mandati: US National Institutes of Health, Research Foundation (Flanders), Cancer …
Controlla
Amplification of LAPTM4B and YWHAZ contributes to chemotherapy resistance and recurrence of breast cancer
Y Li, L Zou, Q Li, B Haibe-Kains, R Tian, Y Li, C Desmedt, C Sotiriou, ...
Nature medicine 16 (2), 214-218, 2010
Mandati: US National Institutes of Health
Controlla
A three-gene model to robustly identify breast cancer molecular subtypes
B Haibe-Kains, C Desmedt, S Loi, AC Culhane, G Bontempi, ...
Journal of the National Cancer Institute 104 (4), 311-325, 2012
Mandati: US National Institutes of Health
Controlla
Genomic characterization of primary invasive lobular breast cancer
C Desmedt, G Zoppoli, G Gundem, G Pruneri, D Larsimont, M Fornili, ...
Journal of clinical oncology 34 (16), 1872-1881, 2016
Mandati: Wellcome Trust, Susan G. Komen
Controlla
Genomic index of sensitivity to endocrine therapy for breast cancer
WF Symmans, C Hatzis, C Sotiriou, F Andre, F Peintinger, P Regitnig, ...
Journal of clinical oncology 28 (27), 4111-4119, 2010
Mandati: US National Institutes of Health
Controlla
HER2 and TOP2A as predictive markers for anthracycline-containing chemotherapy regimens as adjuvant treatment of breast cancer: a meta-analysis of individual patient data
A Di Leo, C Desmedt, JMS Bartlett, F Piette, B Ejlertsen, KI Pritchard, ...
The lancet oncology 12 (12), 1134-1142, 2011
Mandati: Cancer Research UK
Le informazioni sulla pubblicazione e sul finanziamento vengono stabilite automaticamente da un software